Therapy for the sphingolipidoses

Area of Science:

• Biochemistry
• Genetics
• Metabolic Disorders

Background:

• Sphingolipidoses are a class of human metabolic storage diseases.
• These disorders involve the harmful accumulation of glycosphingolipids and phosphosphingolipids.
• A common structural feature of these lipids is the hydrophobic ceramide portion.

Purpose of the Study:

• To define sphingolipidoses and provide examples of specific lipid storage disorders.
• To illustrate the composition of key lipids involved in these diseases.
• To highlight the accumulating lipids in Gaucher disease, Tay-Sachs disease, and Niemann-Pick disease.

Main Methods:

• Characterization of lipid structures, focusing on ceramide and its linkages.
• Identification of accumulating lipids in specific patient populations.
• Classification of lipids based on their carbohydrate components (oligosaccharides, N-acetylneuraminic acid).

Main Results:

• Glucocerebroside accumulation is characteristic of Gaucher disease.
• G(M2) ganglioside accumulation is observed in Tay-Sachs disease.
• Sphingomyelin accumulation is a hallmark of Niemann-Pick disease.

Conclusions:

• Sphingolipidoses result from the buildup of specific lipids due to metabolic defects.
• Understanding lipid composition is crucial for diagnosing and studying these genetic disorders.
• Examples like Gaucher, Tay-Sachs, and Niemann-Pick diseases exemplify the diverse manifestations of sphingolipidosis.